Immunosuppressive therapy and infection after kidney transplantation
- 11 June 2010
- journal article
- Published by Wiley in Transplant Infectious Disease
- Vol. 12 (5), 397-405
- https://doi.org/10.1111/j.1399-3062.2010.00526.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Incisional surgical infection in heart transplantationTransplant Infectious Disease, 2008
- Risk factors for impaired wound healing in sirolimus‐treated renal transplant recipientsClinical Transplantation, 2007
- The use of sirolimus in ganciclovir‐resistant cytomegalovirus infections in renal transplant recipientsClinical Transplantation, 2007
- The addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipientsNephrology, 2007
- Basiliximab Versus Rabbit Anti-thymocyte Globulin for Induction Therapy in Patients After Heart TransplantationThe Journal of Heart and Lung Transplantation, 2006
- Everolimus (Certican) 12-Month Safety and Efficacy Versus Mycophenolate Mofetil in de Novo Renal Transplant RecipientsTransplantation, 2004
- Four‐year follow‐up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantationClinical Transplantation, 2004
- The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipientsTransplantation, 2003
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsThe New England Journal of Medicine, 2003
- Infections in Renal Transplant Recipients Receiving Mycophenolate Versus Azathioprine-Based ImmunosuppressionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002